Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for early postoperative hyperbilirubinemia after liver transplantation
ChiCTR-IPR-16009576Phase 4Recruiting
- Sponsor
- Sun Yat-sen University First Affiliated Hospital Organ Transplant Center
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of methylprednisolone in hyperbilirubinemia and Liver Transplant Complications (2 arms), sponsored by Sun Yat-sen University First Affiliated Hospital Organ Transplant Center. Primary endpoint: Total bilirubin. Started Jul 2016; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
hyperbilirubinemiaLiver Transplant Complications
Beyond the preview
Go deeper on ChiCTR-IPR-16009576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009576.